Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

NCT02206425 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan
DRUG: Prednisone
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DIETARY_SUPPLEMENT: Ascorbic acid
DRUG: PLD
DRUG: Lenalidomide
DRUG: Pomalidomide

Sponsor

Oncotherapeutics

Collaborators

[object Object]